Effects of Exercise on Bone Marrow Adipose Tissue in Children With Overweight/Obesity: Role of Liver Fat
- PMID: 39109799
- PMCID: PMC11834710
- DOI: 10.1210/clinem/dgae547
Effects of Exercise on Bone Marrow Adipose Tissue in Children With Overweight/Obesity: Role of Liver Fat
Abstract
Context: Exercise reduces adiposity, but its influence on bone marrow fat fraction (BMFF) is unknown; nor is it known whether a reduction in liver fat content mediates this reduction.
Objectives: This work aimed to determine whether incorporating exercise into a lifestyle program reduces the lumbar spine (LS) BMFF and to investigate whether changes in liver fat mediate any such effect.
Methods: Ancillary analysis of a 2-arm, parallel, nonrandomized clinical trial was conducted at primary care centers in Vitoria-Gasteiz, Spain. A total of 116 children with overweight/obesity were assigned to a 22-week family-based lifestyle program (control group [n = 57]) or the same program plus an exercise intervention (exercise group [n = 59]). The compared interventions consisted of a family-based lifestyle program (two 90-minute sessions/month) and the same program plus supervised exercise (three 90-minute sessions/week). The primary outcome examined was the change in LS-BMFF between baseline and 22 weeks, as estimated by magnetic resonance imaging. The effect of changes in hepatic fat on LS-BMFF were also recorded.
Results: Mean weight loss difference between groups was 1.4 ± 0.5 kg in favor of the exercise group. Only the children in the exercise group experienced a reduction in LS-BMFF (effect size [Cohen d] -0.42; CI, -0.86 to -0.01). Importantly, 40.9% of the reductions in LS-BMFF were mediated by changes in percentage hepatic fat (indirect effect: β=-0.104; 95% CI, -0.213 to -0.019). The effect of changes in hepatic fat on LS-BMFF was independent of weight loss.
Conclusion: The addition of exercise to a family-based lifestyle program designed to reduce cardiometabolic risk improves bone health by reducing LS-BMFF in children with overweight or obesity. This beneficial effect on bone marrow appears to be mediated by reductions in liver fat.
Keywords: MAFLD; MASLD; NAFLD; bone health; fatty liver; lifestyle; obesity; youth.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
Figures
References
-
- Beekman KM, Duque G, Corsi A, Tencerova M, Bisschop PH, Paccou J. Osteoporosis and bone marrow adipose tissue. Curr Osteoporos Rep. 2023;21(1):45‐55. - PubMed
-
- Gordon RJ, Misra M, Mitchell DM. Osteoporosis and bone fragility in children. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, eds. Endotext. (MA: ): MDText.com, Inc. Copyright © 2000-2023, MDText.com, Inc.; 2000. - PubMed
-
- Ferland-McCollough D, Maselli D, Spinetti G, et al. MCP-1 Feedback loop between adipocytes and mesenchymal stromal cells causes fat accumulation and contributes to hematopoietic stem cell rarefaction in the bone marrow of patients with diabetes. Diabetes. 2018;67(7):1380‐1394. - PubMed
Publication types
MeSH terms
Grants and funding
- PI13/01335/Spanish Ministry of Health's
- DEP2016-78377-R/Spanish Ministry of the Economy Industry and Competitiveness
- ERDF 2014-2020/European Regional Development Funds (ERDF)
- 0011-1365-2019-000152/Regional Government of Navarra's Department of Economic Development
- FJC2018-037925-I/Spanish Ministry of Science and Innovation
